Basic Sciences

JMJD8 Regulates Angiogenic Sprouting and Cellular Metabolism by Interacting With Pyruvate Kinase M2 in Endothelial CellsHighlights

Jes-Niels Boeckel, Anja Derlet, Simone F. Glaser, Annika Luczak, Tina Lucas, Andreas W. Heumüller, Marcus Krüger, Christoph M. Zehendner, David Kaluza, Anuradha Doddaballapur, Kisho Ohtani, Karine Treguer, Stefanie Dimmeler
https://doi.org/10.1161/ATVBAHA.116.307695
Arteriosclerosis, Thrombosis, and Vascular Biology. 2016;36:1425-1433
Originally published May 19, 2016

Jump to

Abstract

Objective—Jumonji C (JmjC) domain–containing proteins modify histone and nonhistone proteins thereby controlling cellular functions. However, the role of JmjC proteins in angiogenesis is largely unknown. Here, we characterize the expression of JmjC domain–containing proteins after inducing endothelial differentiation of murine embryonic stem cells and study the function of JmjC domain–only proteins in endothelial cell (EC) functions.

Approach and Results—We identified a large number of JmjC domain–containing proteins regulated by endothelial differentiation of murine embryonic stem cells. Among the family of JmjC domain–only proteins, Jmjd8 was significantly upregulated on endothelial differentiation. Knockdown of Jmjd8 in ECs significantly decreased in vitro network formation and sprouting in the spheroid assay. JMJD8 is exclusively detectable in the cytoplasm, excluding a function as a histone-modifying enzyme. Mass spectrometry analysis revealed JMJD8-interacting proteins with known functions in cellular metabolism like pyruvate kinase M2. Accordingly, knockdown of pyruvate kinase M2 in human umbilical vein ECs decreased endothelial sprouting in the spheroid assay. Knockdown of JMJD8 caused a reduction of EC metabolism as measured by Seahorse Bioscience extracellular flux analysis. Conversely, overexpression of JMJD8 enhanced cellular oxygen consumption rate of ECs, reflecting an increased mitochondrial respiration.

Conclusions—Jmjd8 is upregulated during endothelial differentiation and regulates endothelial sprouting and metabolism by interacting with pyruvate kinase M2.

Blood vessels are lined with endothelial cells (ECs), which regulate the exchange of nutrients and oxygen within tissues. The outgrowth of new vessels from pre-existing ones, a process named angiogenesis, is essential in organ growth and repair but can also contribute to pathological processes. Angiogenesis is therefore tightly regulated by the demand of the surrounding tissue for oxygen and metabolites.1

A class of proteins characterized by the existence of a Jumonji C (JmjC) domain has been described to function as histone demethylases, which alters chromatin accessibility and thereby regulates gene transcription.2 The enzymatic activity of the protein family depends on the JmjC domain, whereas the presence of additional protein domains leads to their assignment into subgroups.3 For example, C2H2/C5H2 or AT-hook motifs are implicated in the binding and interaction with DNA, whereas plant homeodomain fingers are required for substrate-specific binding.4,5 In addition, some JmjC domain–containing proteins are capable of regulating nonhistone protein functions by hydroxylation or demethylation.6,7 It is already documented that both types of JmjC protein functions are important for the regulation of stem cell plasticity and differentiation.8–11 Recent studies have highlighted the importance of JmjC proteins in the regulation of angiogenesis. Specifically, JHDM1B (KDM2B) mediates in vitro endothelial network formation via FGF2 signaling.12 JMJD6 is required for angiogenic sprouting through controlling the splicing of vascular endothelial growth factor (VEGF) receptor 1,13 whereas JARID1B (KDM5B) epigenetically represses the proangiogenic genes HOXA5 and CCL14, respectively, thereby controlling angiogenesis.14,15 Hypoxia, a condition of reduced oxygen availability, is not only a strong stimulus for the outgrowth of new vessels but induces the expression of several JmjC proteins, such as JHDM2A (KDM3A), JMJD2B (KDM4B), JMJD2C (KDM4C), and JMJD2D (KDM4D).16–18 Additionally, the catalytic activity of the JmjC domain depends on the cofactors Fe(II), 2-oxogluarate, and oxygen.19 Thereby changes in oxygen levels and availability of metabolites profoundly affect the enzymatic activity of JmjC domain proteins and therefore control transcriptional and post-transcriptional downstream effector pathways.20 In this regard, the regulation of transcriptional activity of the transcriptional master regulator under oxygen tension, the hypoxia-inducible factor 1α (HIF1α) by the JmjC domain–containing protein FIH1 (HIF1AN), is most prominent. The transcription factor HIF1α is hydroxylated by FIH1 via an oxygen-consuming reaction and thereby is transcriptionally inhibited under normal oxygen conditions.6,7,21

However, the regulation of JmjC proteins in EC differentiation and the function of the JmjC domain–only proteins namely, No66 (C14orf169), Jmjd4, and Jmjd8 are unknown.

Here, we show that endothelial differentiation of embryonic stem cells (ESC) significantly regulates a variety of JmjC proteins including Jmjd8. Among the JmjC domain–only proteins, JMJD8 was the only family member that controls angiogenesis. Interestingly, JMJD8 binds to PKM2 and regulates angiogenic sprouting and cellular metabolism of ECs.

Materials and Methods

Materials and Methods are available in the online-only Data Supplement.

Results

Regulation of JmjC Domain–Containing Protein Expression by Endothelial Differentiation of ESCs

Endothelial differentiation was induced as previously described and validated by the increased expression of endothelial marker genes and concomitant downregulation of pluripotency markers such as Oct4 (Pou5f1; Figure 1A–1C).22 Among the 30 annotated JmjC domain–containing proteins, 11 proteins were significantly upregulated, whereas only 2 JmjC domain proteins were significantly decreased at day 7 of endothelial differentiation (Figure 1D). To determine, whether these JmjC proteins are specific for the endothelial lineage, we induced cardiac differentiation of ESC. We found a significant increase of 8 JmjC proteins, whereas 8 JmjC proteins were downregulated at day 8 of cardiac differentiation (Figure I A–IC in the online-only Data Supplement). At day 7 of endothelial differentiation, expression of Jmjd5 (Kdm8), Fih1 (Hif1an), Jmjd4, Jmjd6 (Ptdsr), and Jmjd8 were significantly higher compared with day 0, whereas Hspbap1 was the only JmjC domain–only protein whose expression was significantly decreased (Figure 1D). In contrast, at day 8 of cardiac differentiation, Mina53 (Mina), Jmjd7, and Hspbap1 were significantly decreased, and only Jmjd8 showed a significantly higher expression level when compared with day 0 (Figure IA in the online-only Data Supplement).

Figure 1.
Figure 1.

Screening for Jumonji C (JmjC) domain–containing protein expression in endothelial differentiation of mouse embryonic stem cells (ESCs). A, Mouse ESCs were cultured in suspension. On day 2 of differentiation, 30 μg/mL vascular endothelial growth factor was added to the medium. Endothelial differentiation was stopped at days 4 and 7, and total RNA was isolated. Expression of the stemness gene Oct4 during endothelial differentiation of murine ESCs. Expression of endothelial markers (B) Pecam and (C) VE-cadherin in endothelial differentiation of murine ESCs. D, Expression of 30 JmjC domain–containing proteins was assessed using quantitative reverse transcription polymerase chain reaction. mRNA expression was normalized to Gapdh expression using the 2−ΔCt method. Inset: overview of the JmjC family subgroups. Reprinted from Klose et al3 with permission of the publisher. Copyright ©2006, Nature Publishing Group. Data are shown as mean±SEM, fold change day 0. n=3. Statistical significance was determined using Student t test; *P<0.05.

JMJD8 Acts as a Proangiogenic JmjC Protein In Vitro and In Vivo

To date, only the function of JMJD6 and FIH1 were evaluated in ECs, but a previous study identified JMJD8, NO66 (C14orf169), and JMJD6 the 3 highest expressed JmjC domain–only proteins in human umbilical vein ECs.13,14,23

Therefore, 3 JmjC domain–only proteins Jmjd8, NO66, and Jmjd4 were selected for further functional analysis. To investigate the function of JMJD4, JMJD8, and NO66 in ECs, we used RNA interference (siRNA)–mediated knockdown (Figure 2A). Only the knockdown of JMJD8, but not JMJD4 or NO66, significantly reduced endothelial network formation in an in vitro Matrigel assay (Figure 2B). Moreover, we tested the response of ECs in 2D matrigel culture, which increased vascular endothelial growth factor and vascular endothelial growth factor receptor 1 expression (Figure 2C–2E). Cultivation of ECs on Matrigel induced a significant upregulation of JMJD8 and downregulation of NO66 expression, whereas JMJD4 expression was not changed (Figure 2C).

Figure 2.
Figure 2.

Function of selected JmjC domain–only proteins in endothelial cells. A, siRNA-mediated knockdown of NO66, JMJD4, and JMJD8 was confirmed using quantitative polymerase chain reaction (qPCR; n=3). Values normalized to RPLP0 (ribosomal protein, large, P0) mRNA. B, Network formation on matrigel after siNO66, siJMJD4, and siJMJD8 treatment (n=3). Representative pictures are shown in top. *P<0.05 vs Scr-1; #P<0.05 vs Scr-2. C, Human umbilical vein endothelial cells (HUVECs) were either cultured on plastic dishes or on matrigel. Incubated for 24 h followed by analysis of mRNA expression of NO66, JMJD4, and JMJD8 using qPCR (n=3). Data are shown as fold incubation on plastic dish. D, Expression of vascular endothelial growth factor (VEGF) and VEGFR1 mRNA after culturing HUVECs on plastic dishes and on matrigel (n=3). Data is shown as fold incubation on plastic dish. E, Representative pictures of HUVECs cultured on plastic dishes or on matrigel for 24 h. Data are mean±SEM. Statistical significance was determined with Student t test; *P<0.05.

To confirm the angiogenic phenotype of JMJD8 knockdown in ECs, we used 2 additional siRNAs targeting JMJD8 (Figure 3A). Knockdown by all 3 siRNAs targeting JMJD8 significantly reduced network formation in a Matrigel assay (Figure 3B) and endothelial sprouting in a spheroid assay (Figure 3C). On the contrary, survival, cell cycle, and transmigration capacity of ECs were not affected by JMJD8 knockdown (Figure IIA–IIC in the online-only Data Supplement). Because JMJD8 was increased during endothelial differentiation, we further investigated whether JMJD8 is involved in regulation of endothelial marker gene expression during ESC differentiation. Indeed, silencing of JMJD8 in ESC prevented vascular endothelial growth factor–induced EC differentiation as indicated by significantly reduced expression of the endothelial marker gene VE-cadherin (Figure 3D).

Figure 3.
Figure 3.

Function of JMJD8 in endothelial cells. A, siRNA-mediated knockdown of JMJD8 using 3 siRNAs was confirmed using qPCR and immunoblot (inlet). mRNA expression was normalized to RPLP0 (ribosomal protein, large, P0) expression using the 2−ΔCt method. B, Network formation on matrigel after siJMJD8 treatment using 3 siRNAs. Representative pictures are shown in top. C, Sprouting of spheroids after siJmjd8 treatment using 3 siRNAs. Representative spheroids are shown in upper panel. D, VE-cadherin expression in mES (murine embryonic stem cells) after shRNA-mediated knockdown of Jmjd8 after 0, 7, and 10 days of endothelial differentiation. E, Capillaries in skeletal muscle of Jmjd8−/− and wild-type mice. Wheat germ agglutinin (WGA) was used to stain plasma membranes and lectin to stain vessels. F, Quantification of capillaries in skeletal muscle of Jmjd8−/− and wild-type mice (N=4 each group). Statistical significance was determined with Student test; *P<0.05 vs Scr-1; #P<0.05 vs Scr-2.

Having demonstrated that silencing of JMJD8 reduced angiogenic sprouting and EC differentiation in vitro, we examined the in vivo function of JMJD8 by generating JMJD8−/− mice (Figure IIIA and IIIB in the online-only Data Supplement). JMJD8−/− showed no obvious phenotype, suggesting that embryonic vascular development was not affected. However, the number of capillaries in muscle tissue was significantly reduced (Figure 3E and 3F).

JMJD8 Has an Extranuclear Localization and Binds to PKM2 in ECs

JmjC domain–containing proteins have been predominantly found to be localized in the nucleus, associated with chromatin. In contrast, we found JMJD8 localized extranuclear in ECs, as demonstrated by immunofluorescence staining of flag-tagged JMJD8 (Figure 4A). To gain further insight into the function of JMJD8, mass spectrometry analysis after immunoprecipitation of JMJD8 was performed. The proteins interacting with Jmjd8 included proteins of cellular metabolism such as pyruvate kinase M2 (PKM2) and phosphofructokinase 1 (Figure 4B). Indeed, gene ontology enrichment analysis revealed that proteins related to metabolic processes account for substantial portion of proteins that bind to JMJD8 (Figure 4C). The protein interactions of the 4 selected proteins phosphofructokinase 1, JAK1, CANX, and PKM2 with Jmjd8 were confirmed by coimmunoprecipitation in human umbilical vein ECs. Because overexpression of proteins is not efficient in ECs, we confirmed the interaction of PKM2 with JMJD8 in HEK293 (human embryonic kidney 293) cells (Figure 4D). Consistently, we found JMJD8 outside the nucleus together with PKM2 after separation of cytoplasmic and nuclear proteins using immunoblot (Figure 4E). The interaction of JMJD8 with PKM2 was further confirmed by coimmunoprecipitation using PKM2-V5 and Jmjd8-FLAG overexpression constructs (Figure 4F). To identify the interaction site, we generated deletion constructs of JMJD8 and coexpressed the constructs with V5-tagged PKM2. The N-terminal deletion of amino acids (aa) 1 to 124 (Δ3) and the deletion of aa 63 to 214 (Δ4) did not prevent binding of PKM2 (Figure IVA and IVB in the online-only Data Supplement). However, N-terminal deletion of aa 1 to 200 of JMJD8 (Δ2 construct) did prevent binding to PKM2 (Figure IVA and IVB in the online-only Data Supplement), suggesting that PKM2 interaction with JMJD8 occurs in the region between aa 63 and 124. Interestingly, PKM2 has recently been shown to promote angiogenesis in ECs,24,25 suggesting that cytoplasmic JMJD8 could regulate angiogenesis by controlling metabolic functions of EC, a mechanism which was recently shown to play a key role in regulating angiogenesis.26,27

Figure 4.
Figure 4.

Extranuclear localization of JMJD8 in endothelial cells and interaction with pyruvate kinase M2 (PKM2). A, Flag-tagged JMJD8 was transfected into human umbilical vein endothelial cells (HUVECs) and visualized using Cy3-coupled antiflag antibodies. Right, Analysis of Jmjd8 staining light intensity along a single line drawn across a cell. B, Flag-tagged JMJD8 was precipitated using anti–flag-coupled magnetic beads. Co-immunoprecipitated proteins were analyzed using mass spectrometry. C, Gene ontology analysis on biological processes involved in the top 50 proteins bound to Jmjd8 identified by MS. D, Proteins binding to JMJD8 were validated in HUVEC and HEK293 (human embryonic kidney 293) cells with coimmunoprecipitation targeting Flag-tagged JMJD8. Lysates of cells transfected with untagged green fluorescent protein (GFP) were used as controls incubated with anti–flag-coupled magnetic beads. E, Cellular localization of JMJD8 and PKM2 was analzyed using immunoblot in cytoplasmic and nuclear seperated protein lysates. Topo I and Gapdh were used as controls for nuclear (N) and cytoplasmic (C) proteins respectively. F, Flag-tagged JMJD8 and V5-tagged PKM2 were transfected into HEK293 cells using RNAiMAX. V5-PKM2 was immunoprecipitated using V5-tagged magnetic beads, and binding to JMJD8 was analyzed by immunoblotting.

JMJD8 Regulates Metabolism in ECs

To investigate if the function of JMJD8 in endothelial sprouting is mediated by the interaction with PKM2, PKM2 was silenced with 3 siRNAs (Figure 5A). All 3 small interfering RNAs directed against PKM2 significantly reduced endothelial sprouting in the spheroid assays (Figure 5B). To investigate a potential influence of JMJD8 on metabolism in ECs, Seahorse Flux analysis was performed. The lactate production reflecting the glycolytic cell function was determined by the measuring extracellular acidification rate after shJMJD8 and JMJD8 transduction (Figure VA and VB in the online-only Data Supplement). The shRNA-mediated knockdown of Jmjd8 resulted in a decreased basal glycolysis, glycolysis, and oligomycin-induced maximal glycolysis, but only maximal glycolytic capacity was significantly reduced (Figure 5C and 5D). Additionally, cells isolated from JMJD8−/− mice showed a significantly reduced glycolysis (Figure VIA and VIB in the online-only Data Supplement). Conversely, overexpression of wild-type JMJD8 enhanced the maximal glycolytic function of ECs, but these data failed to achieve significance (Figure 5E).

Figure 5.
Figure 5.

JMJD8 regulates metabolism in endothelial cells. A, siRNA-mediated knockdown of PKM2 using 3 siRNAs was confirmed using qPCR. mRNA expression normalized to RPLP0 (ribosomal protein, large, P0) expression using the 2−ΔCt method. Inset: PKM2 knockdown on protein level, α-Tubulin was used as a loading control. B, Sprouting of spheroids after siPKM2 treatment using 3 siRNAs (n=3). *P<0.05 vs Scr-1; #P<0.05 vs Scr-2. Inlet: Representative spheroids. Bar=200 μm. C, Extracellular acidification rate (ECAR) profile demonstrating glycolytic function in (D) shCONTROL- and shJMJD8-transduced cells and (E) mock- and Jmjd8-transduced cells. Vertical lines indicate the time of addition of glucose, oligomycin, and 2-deoxy-d glucose (n=4). F, Oxygen consumption rate (OCR) profile demonstrating mitochondrial respiration function in (G) shCONTROL- and shJMJD8- transduced Human umbilical vein endothelial cells (HUVECs) and (H) MOCK- and JMJD8-transduced (HUVECs). Vertical lines indicate the time of addition of oligomycin, carbonyl cyanide 4-trifluoromethoxy-phenylhydrazone, antimycin A, and rotenone (n=4). Statistical significance was determined with Student t test comparing MOCK with JMJD8 cells and shCONTROL with shJMJD8 cells; n=4. *P<0.05.

We next analyzed the cellular oxygen consumption rate reflecting the mitochondrial respiration rate in cells. A significant decrease of the maximal respiration capacity induced by carbonyl cyanide 4-(trifluoromethoxy)-phenylhydrazone in ECs was observed after shJMJD8 compared with shRNA control transduced cells, whereas overexpression of JMJD8 significantly increased the maximal oxygen consumption rate compared with mock-transduced cells (Figure 5E). These data suggest that JMJD8 controls glycolysis and respiration of ECs.

To finally test whether JMJD8 controls the enzymatic activity of PKM2, we measured pyruvate synthesis. Whereas silencing of JMJD8 significantly reduced pyruvate synthesis, overexpression significantly enhanced the formation of pyruvate in ECs (Figure VII in the online-only Data Supplement), suggesting that JMJD8 controls generation of pyruvate.

Discussion

When reducing the expression of NO66, JMJD4, and JMJD8 by siRNA-mediated silencing, only knockdown of JMJD8 impaired sprouting angiogenesis. It has recently been shown that several JmjC domain–containing proteins such as JMJD6 or JARID1B are essential for sprouting angiogenesis by modifying histone as well as nonhistone proteins.13–15 The JmjC domain–only subgroup was implicated in control of the hypoxic response6,7 and further was shown to regulate angiogenesis.13 The lysine demethylase No66 regulates osteoblast differentiation,28 whereas no functional role are described for JMJD4 and JMJD8 to date. It has recently been shown that many JmjC proteins regulate cellular proliferation and therefore are involved in the malignancy of cancer progression. In this regard, Jmjd2b (Kdm4b) and Mina53 (Mina) regulate cellular proliferation in physiological states like spermatogenesis and in pathophysiological conditions like cancer.29,30 Although Jmjd8 did not affect proliferation of ECs, these findings do not exclude proliferation regulatory effects in other cell types. Most JmjC proteins analyzed to date have been found in the nucleus controlling histone states, only few JmjC proteins were reported to be outside of the nucleus like JMJD8.31,32 Analyzing proteins bound to JMJD8 revealed enzymes that have been shown to be important regulators of metabolism like PKM2 and phosphofructokinase. Metabolism controls angiogenesis. In this regard, endothelial migration and proliferation, as essential steps in angiogenesis, were recently shown to be regulated by metabolism. The outgrowth of new vessels is in particular dependent on glucose whose availability is controlled by glycolysis-regulating enzymes like PFKFB3 (6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3).26,27,33,34 Specifically PKM2, which is the rate-limiting enzyme of glycolysis, controlling the conversion of phosphoenolpyruvate to pyruvate, has recently been shown to promote angiogenesis in ECs.24,25 Indeed, we found that knockdown of PKM2 resulting in impaired angiogenic sprouting and JMJD8 stimulates the formation of pyruvate in ECs. The precise mechanism of how JMJD8 regulates PKM2 is currently unknown. However, we found that the region between aa 63 and 124 of JMJD8 is important for binding to PKM2. A subsequent analysis for this region using the SMART tool (http://smart.embl-heidelberg.de) revealed 2 low-complexity regions (aa72-88/aa92-106) as only protein motifs in this region. Indeed, low-complexity region motifs have been shown to modulate protein–protein interactions.35 Interestingly, JMJD5, a closely related family member which was previously shown to negatively regulate osteoclastogenesis and human circadian systems, was recently identified to regulate the nuclear translocation of PKM2 and thereby reprogramming HIF-1α–mediated glucose metabolism.31,36,37 This regulation is consistent with our observation that JMJD8 is enhancing the metabolic activity of ECs by increasing the oxygen consumption and the maximal glycolytic function. Of note, we also showed a modulation of maximal oxygen consumption by JMJD8, indicating that mitochondrial function may be affected beyond the level of pyruvate formation. Indeed, silencing of JMJD8 reduced the mitochondrial content in ECs (Figure VIIIA in the online-only Data Supplement), suggesting an additional layer of modulation. JmjC domain–containing proteins have important roles in regulating stem cell plasticity and differentiation.8–11 Here, we show that endothelial and cardiac differentiation of ESCs significantly affect a variety of JmjC proteins. Most JmjC genes were upregulated during differentiation into the endothelial lineage, whereas cardiac differentiation reduced most JmjC proteins on mRNA level. Indeed, we found a significant reduction in cardiac differentiation of Jmjd1a (Kdm3a) and Jmjd2c (Kdm4c), which have been shown to regulate self-renewal in ESCs.38 We further identified Jmjd8, which is the only gene significantly upregulated from the JmjC domain–only subgroup, implying a potential role in cardiovascular development. Mice lacking JmjC proteins like Jmjd6 or the name-giving enzyme of the JmjC protein family Jarid2 (JMJ) have a disturbed cardiac development already in the embryonic stage, which potentially is the cause for pre- or postnatal lethality.39–41 However, Jmjd8−/− mice are viable and do not show an obvious phenotype, suggesting that Jmjd8 is not essential for embryonic vascular development. Nevertheless, we found a significant reduction in glycolytic capacity in cells isolated from Jmjd8 knockout mice, supporting the results of our in vitro studies. Moreover, Jmjd8-deficient mice revealed a reduced number of capillaries in skeletal muscles in adulthood. To dissect the direct influence of Jmjd8 on the endothelium in adulthood, an endothelium-specific knockout would be necessary, which is currently unavailable.

Although previous studies reported a role of JmjC domain–containing proteins in EC biology, this study demonstrates that a JmjC domain–containing protein interacts with EC metabolism. Indeed, JmjC proteins have been proposed as metabolic sensors through their dependence on metabolites like 2-oxoglutarate or oxygen.42 Together, our data implicate a critical function of JMJD8 in the metabolic control of angiogenesis.

Acknowledgments

We would like to thank Tino Roexe and Graziella Becker-Pergola for expert technical support.

Sources of Funding

The study was supported by the Deutsche Forschungsgemeinschaft (SFB834/B5) and LOEWE Center for Cell and Gene Therapy (State of Hesse) to S. Dimmeler. C.M. Zehendner was supported by a Goethe-University startup grant. T. Lucas was supported by an ECCPS startup grant.

Disclosures

None.

Footnotes

  • Received November 12, 2015.
  • Accepted April 25, 2016.

References

  1. 1.↵
    1. Carmeliet P
    . Angiogenesis in life, disease and medicine. Nature. 2005;438:932–936. doi: 10.1038/nature04478.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Tsukada Y,
    2. Fang J,
    3. Erdjument-Bromage H,
    4. Warren ME,
    5. Borchers CH,
    6. Tempst P,
    7. Zhang Y
    . Histone demethylation by a family of JmjC domain-containing proteins. Nature. 2006;439:811–816. doi: 10.1038/nature04433.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Klose RJ,
    2. Kallin EM,
    3. Zhang Y
    . JmjC-domain-containing proteins and histone demethylation. Nat Rev Genet. 2006;7:715–727. doi: 10.1038/nrg1945.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Horton JR,
    2. Upadhyay AK,
    3. Qi HH,
    4. Zhang X,
    5. Shi Y,
    6. Cheng X
    . Enzymatic and structural insights for substrate specificity of a family of jumonji histone lysine demethylases. Nat Struct Mol Biol. 2010;17:38–43. doi: 10.1038/nsmb.1753.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Huang Y,
    2. Chen D,
    3. Liu C,
    4. Shen W,
    5. Ruan Y
    . Evolution and conservation of JmjC domain proteins in the green lineage. Mol Genet Genomics. 2016;291:33–49. doi: 10.1007/s00438-015-1089-4.
    OpenUrlCrossRef
  6. 6.↵
    1. Hewitson KS,
    2. McNeill LA,
    3. Riordan MV,
    4. Tian YM,
    5. Bullock AN,
    6. Welford RW,
    7. Elkins JM,
    8. Oldham NJ,
    9. Bhattacharya S,
    10. Gleadle JM,
    11. Ratcliffe PJ,
    12. Pugh CW,
    13. Schofield CJ
    . Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. J Biol Chem. 2002;277:26351–26355. doi: 10.1074/jbc.C200273200.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Lando D,
    2. Peet DJ,
    3. Gorman JJ,
    4. Whelan DA,
    5. Whitelaw ML,
    6. Bruick RK
    . FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev. 2002;16:1466–1471. doi: 10.1101/gad.991402.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Zhu H,
    2. Hu S,
    3. Baker J
    . JMJD5 regulates cell cycle and pluripotency in human embryonic stem cells. Stem Cells. 2014;32:2098–2110. doi: 10.1002/stem.1724.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Ishimura A,
    2. Minehata K,
    3. Terashima M,
    4. Kondoh G,
    5. Hara T,
    6. Suzuki T
    . Jmjd5, an H3K36me2 histone demethylase, modulates embryonic cell proliferation through the regulation of Cdkn1a expression. Development. 2012;139:749–759. doi: 10.1242/dev.074138.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Peng JC,
    2. Valouev A,
    3. Swigut T,
    4. Zhang J,
    5. Zhao Y,
    6. Sidow A,
    7. Wysocka J
    . Jarid2/Jumonji coordinates control of PRC2 enzymatic activity and target gene occupancy in pluripotent cells. Cell. 2009;139:1290–1302. doi: 10.1016/j.cell.2009.12.002.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Wang J,
    2. Zhang M,
    3. Zhang Y,
    4. Kou Z,
    5. Han Z,
    6. Chen DY,
    7. Sun QY,
    8. Gao S
    . The histone demethylase JMJD2C is stage-specifically expressed in preimplantation mouse embryos and is required for embryonic development. Biol Reprod. 2010;82:105–111. doi: 10.1095/biolreprod.109.078055.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Kottakis F,
    2. Polytarchou C,
    3. Foltopoulou P,
    4. Sanidas I,
    5. Kampranis SC,
    6. Tsichlis PN
    . FGF-2 regulates cell proliferation, migration, and angiogenesis through an NDY1/KDM2B-miR-101-EZH2 pathway. Mol Cell. 2011;43:285–298. doi: 10.1016/j.molcel.2011.06.020.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Boeckel JN,
    2. Guarani V,
    3. Koyanagi M,
    4. Roexe T,
    5. Lengeling A,
    6. Schermuly RT,
    7. Gellert P,
    8. Braun T,
    9. Zeiher A,
    10. Dimmeler S
    . Jumonji domain-containing protein 6 (Jmjd6) is required for angiogenic sprouting and regulates splicing of VEGF-receptor 1. Proc Natl Acad Sci USA. 2011;108:3276–3281. doi: 10.1073/pnas.1008098108.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Fork C,
    2. Gu L,
    3. Hitzel J,
    4. Josipovic I,
    5. Hu J,
    6. SzeKa Wong M,
    7. Ponomareva Y,
    8. Albert M,
    9. Schmitz SU,
    10. Uchida S,
    11. Fleming I,
    12. Helin K,
    13. Steinhilber D,
    14. Leisegang MS,
    15. Brandes RP
    . Epigenetic Regulation of Angiogenesis by JARID1B-Induced Repression of HOXA5. Arterioscler Thromb Vasc Biol. 2015;35:1645–1652. doi: 10.1161/ATVBAHA.115.305561.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Li Q,
    2. Shi L,
    3. Gui B,
    4. Yu W,
    5. Wang J,
    6. Zhang D,
    7. Han X,
    8. Yao Z,
    9. Shang Y
    . Binding of the JmjC demethylase JARID1B to LSD1/NuRD suppresses angiogenesis and metastasis in breast cancer cells by repressing chemokine CCL14. Cancer Res. 2011;71:6899–6908. doi: 10.1158/0008-5472.CAN-11-1523.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Tausendschön M,
    2. Dehne N,
    3. Brüne B
    . Hypoxia causes epigenetic gene regulation in macrophages by attenuating Jumonji histone demethylase activity. Cytokine. 2011;53:256–262. doi: 10.1016/j.cyto.2010.11.002.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Beyer S,
    2. Kristensen MM,
    3. Jensen KS,
    4. Johansen JV,
    5. Staller P
    . The histone demethylases JMJD1A and JMJD2B are transcriptional targets of hypoxia-inducible factor HIF. J Biol Chem. 2008;283:36542–36552. doi: 10.1074/jbc.M804578200.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Pollard PJ,
    2. Loenarz C,
    3. Mole DR,
    4. McDonough MA,
    5. Gleadle JM,
    6. Schofield CJ,
    7. Ratcliffe PJ
    . Regulation of Jumonji-domain-containing histone demethylases by hypoxia-inducible factor (HIF)-1alpha. Biochem J. 2008;416:387–394. doi: 10.1042/BJ20081238.
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    1. Ozer A,
    2. Bruick RK
    . Non-heme dioxygenases: cellular sensors and regulators jelly rolled into one? Nat Chem Biol. 2007;3:144–153. doi: 10.1038/nchembio863.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Karuppagounder SS,
    2. Kumar A,
    3. Shao DS,
    4. Zille M,
    5. Bourassa MW,
    6. Caulfield JT,
    7. Alim I,
    8. Ratan RR
    . Metabolism and epigenetics in the nervous system: creating cellular fitness and resistance to neuronal death in neurological conditions via modulation of oxygen-, iron-, and 2-oxoglutarate-dependent dioxygenases. Brain Res. 2015;1628(pt B):273–287. doi: 10.1016/j.brainres.2015.07.030.
    OpenUrlCrossRef
  21. 21.↵
    1. Mahon PC,
    2. Hirota K,
    3. Semenza GL
    . FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev. 2001;15:2675–2686. doi: 10.1101/gad.924501.
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    1. Tréguer K,
    2. Heinrich EM,
    3. Ohtani K,
    4. Bonauer A,
    5. Dimmeler S
    . Role of the microRNA-17-92 cluster in the endothelial differentiation of stem cells. J Vasc Res. 2012;49:447–460. doi: 10.1159/000339429.
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. So JH,
    2. Kim JD,
    3. Yoo KW,
    4. Kim HT,
    5. Jung SH,
    6. Choi JH,
    7. Lee MS,
    8. Jin SW,
    9. Kim CH
    . FIH-1, a novel interactor of mindbomb, functions as an essential anti-angiogenic factor during zebrafish vascular development. PLoS One. 2014;9:e109517. doi: 10.1371/journal.pone.0109517.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Cairns RA,
    2. Harris IS,
    3. Mak TW
    . Regulation of cancer cell metabolism. Nat Rev Cancer. 2011;11:85–95. doi: 10.1038/nrc2981.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Li L,
    2. Zhang Y,
    3. Qiao J,
    4. Yang JJ,
    5. Liu ZR
    . Pyruvate kinase M2 in blood circulation facilitates tumor growth by promoting angiogenesis. J Biol Chem. 2014;289:25812–25821. doi: 10.1074/jbc.M114.576934.
    OpenUrlAbstract/FREE Full Text
  26. 26.↵
    1. De Bock K,
    2. Georgiadou M,
    3. Schoors S,
    4. et al
    . Role of PFKFB3-driven glycolysis in vessel sprouting. Cell. 2013;154:651–663. doi: 10.1016/j.cell.2013.06.037.
    OpenUrlCrossRefPubMed
  27. 27.↵
    1. Doddaballapur A,
    2. Michalik KM,
    3. Manavski Y,
    4. Lucas T,
    5. Houtkooper RH,
    6. You X,
    7. Chen W,
    8. Zeiher AM,
    9. Potente M,
    10. Dimmeler S,
    11. Boon RA
    . Laminar shear stress inhibits endothelial cell metabolism via KLF2-mediated repression of PFKFB3. Arterioscler Thromb Vasc Biol. 2015;35:137–145. doi: 10.1161/ATVBAHA.114.304277.
    OpenUrlAbstract/FREE Full Text
  28. 28.↵
    1. Sinha KM,
    2. Yasuda H,
    3. Zhou X,
    4. deCrombrugghe B
    . Osterix and NO66 histone demethylase control the chromatin of Osterix target genes during osteoblast differentiation. J Bone Miner Res. 2014;29:855–865. doi: 10.1002/jbmr.2103.
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. Tsuneoka M,
    2. Nishimune Y,
    3. Ohta K,
    4. Teye K,
    5. Tanaka H,
    6. Soejima M,
    7. Iida H,
    8. Inokuchi T,
    9. Kimura H,
    10. Koda Y
    . Expression of Mina53, a product of a Myc target gene in mouse testis. Int J Androl. 2006;29:323–330. doi: 10.1111/j.1365-2605.2005.00572.x.
    OpenUrlCrossRefPubMed
  30. 30.↵
    1. Tan XP,
    2. Dong WG,
    3. Zhang Q,
    4. Yang ZR,
    5. Lei XF,
    6. Ai MH
    . Potential effects of Mina53 on tumor growth in human pancreatic cancer. Cell Biochem Biophys. 2014;69:619–625. doi: 10.1007/s12013-014-9841-7.
    OpenUrlCrossRef
  31. 31.↵
    1. Wang HJ,
    2. Hsieh YJ,
    3. Cheng WC,
    4. Lin CP,
    5. Lin YS,
    6. Yang SF,
    7. Chen CC,
    8. Izumiya Y,
    9. Yu JS,
    10. Kung HJ,
    11. Wang WC
    . JMJD5 regulates PKM2 nuclear translocation and reprograms HIF-1α-mediated glucose metabolism. Proc Natl Acad Sci USA. 2014;111:279–284. doi: 10.1073/pnas.1311249111.
    OpenUrlAbstract/FREE Full Text
  32. 32.↵
    1. Hyseni A,
    2. van der Groep P,
    3. van der Wall E,
    4. van Diest PJ
    . Subcellular FIH-1 expression patterns in invasive breast cancer in relation to HIF-1α expression. Cell Oncol (Dordr). 2011;34:565–570. doi: 10.1007/s13402-011-0053-5.
    OpenUrlCrossRefPubMed
  33. 33.↵
    1. Eichmann A,
    2. Simons M
    . Need glucose to sprout: local metabolic control of angiogenesis. EMBO Mol Med. 2013;5:1459–1461. doi: 10.1002/emmm.201303174.
    OpenUrlFREE Full Text
  34. 34.↵
    1. De Bock K,
    2. Georgiadou M,
    3. Carmeliet P
    . Role of endothelial cell metabolism in vessel sprouting. Cell Metab. 2013;18:634–647. doi: 10.1016/j.cmet.2013.08.001.
    OpenUrlCrossRefPubMed
  35. 35.↵
    1. Toll-Riera M,
    2. Radó-Trilla N,
    3. Martys F,
    4. Albà MM
    . Role of low-complexity sequences in the formation of novel protein coding sequences. Mol Biol Evol. 2012;29:883–886. doi: 10.1093/molbev/msr263.
    OpenUrlAbstract/FREE Full Text
  36. 36.↵
    1. Youn MY,
    2. Yokoyama A,
    3. Fujiyama-Nakamura S,
    4. Ohtake F,
    5. Minehata K,
    6. Yasuda H,
    7. Suzuki T,
    8. Kato S,
    9. Imai Y
    . JMJD5, a Jumonji C (JmjC) domain-containing protein, negatively regulates osteoclastogenesis by facilitating NFATc1 protein degradation. J Biol Chem. 2012;287:12994–13004. doi: 10.1074/jbc.M111.323105.
    OpenUrlAbstract/FREE Full Text
  37. 37.↵
    1. Jones MA,
    2. Covington MF,
    3. DiTacchio L,
    4. Vollmers C,
    5. Panda S,
    6. Harmer SL
    . Jumonji domain protein JMJD5 functions in both the plant and human circadian systems. Proc Natl Acad Sci USA. 2010;107:21623–21628. doi: 10.1073/pnas.1014204108.
    OpenUrlAbstract/FREE Full Text
  38. 38.↵
    1. Loh YH,
    2. Zhang W,
    3. Chen X,
    4. George J,
    5. Ng HH
    . Jmjd1a and Jmjd2c histone H3 Lys 9 demethylases regulate self-renewal in embryonic stem cells. Genes Dev. 2007;21:2545–2557. doi: 10.1101/gad.1588207.
    OpenUrlAbstract/FREE Full Text
  39. 39.↵
    1. Mysliwiec MR,
    2. Bresnick EH,
    3. Lee Y
    . Endothelial Jarid2/Jumonji is required for normal cardiac development and proper Notch1 expression. J Biol Chem. 2011;286:17193–17204. doi: 10.1074/jbc.M110.205146.
    OpenUrlAbstract/FREE Full Text
  40. 40.↵
    1. Böse J,
    2. Gruber AD,
    3. Helming L,
    4. Schiebe S,
    5. Wegener I,
    6. Hafner M,
    7. Beales M,
    8. Köntgen F,
    9. Lengeling A
    . The phosphatidylserine receptor has essential functions during embryogenesis but not in apoptotic cell removal. J Biol. 2004;3:15. doi: 10.1186/jbiol10.
    OpenUrlCrossRefPubMed
  41. 41.↵
    1. Schneider JE,
    2. Böse J,
    3. Bamforth SD,
    4. Gruber AD,
    5. Broadbent C,
    6. Clarke K,
    7. Neubauer S,
    8. Lengeling A,
    9. Bhattacharya S
    . Identification of cardiac malformations in mice lacking Ptdsr using a novel high-throughput magnetic resonance imaging technique. BMC Dev Biol. 2004;4:16. doi: 10.1186/1471-213X-4-16.
    OpenUrlCrossRefPubMed
  42. 42.↵
    1. Salminen A,
    2. Kauppinen A,
    3. Kaarniranta K
    . 2-Oxoglutarate-dependent dioxygenases are sensors of energy metabolism, oxygen availability, and iron homeostasis: potential role in the regulation of aging process. Cell Mol Life Sci. 2015;72:3897–3914. doi: 10.1007/s00018-015-1978-z.
    OpenUrlCrossRef

Highlights

  • Jmjd8 was significantly upregulated during endothelial differentiation of embryonic stem cells.

  • Knockdown of Jmjd8 in endothelial cells significantly decreased in vitro network formation and sprouting in the spheroid assay.

  • Mass spectrometry analysis revealed JMJD8-interacting proteins with known functions in cellular metabolism like pyruvate kinase M2.

  • Knockdown of Jmjd8 decreased pyruvate kinase M2 enzymatic activity, whereas overexpression of Jmjd8 led to increased pyruvate kinase M2 enzymatic activity.

  • Knockdown of JMJD8 caused a reduction of endothelial cell metabolism as measured. Conversely, overexpression of JMJD8 enhanced cellular oxygen consumption rate of endothelial cells, reflecting an increased mitochondrial respiration.

View Abstract

This Issue

Jump to

Article Tools

Share this Article

  • Email
  • JMJD8 Regulates Angiogenic Sprouting and Cellular Metabolism by Interacting With Pyruvate Kinase M2 in Endothelial CellsHighlights
    Jes-Niels Boeckel, Anja Derlet, Simone F. Glaser, Annika Luczak, Tina Lucas, Andreas W. Heumüller, Marcus Krüger, Christoph M. Zehendner, David Kaluza, Anuradha Doddaballapur, Kisho Ohtani, Karine Treguer and Stefanie Dimmeler
    Arteriosclerosis, Thrombosis, and Vascular Biology. 2016;36:1425-1433, originally published May 19, 2016
    https://doi.org/10.1161/ATVBAHA.116.307695
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Subjects